arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Amylyx Pharmaceuticals, Inc.

AMLX

$22.95 ▼ -1.23 (-5.09%) at close

22 Visible periods

26 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Amylyx Pharmaceuticals, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.5B

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -12.7% ↘

FCF / Share $-0.33

Trailing P/E —

Price / Book 9.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

22-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↑ +100.0% —

Net Income Profit after all expenses

$-41.28M

↓ -15.0% —

Operating Margin Operating profit as % of sales

-137.8%

↓ -7825.9% —

FCF / Share Free cash flow per share

$-0.33

↑ +28.2% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	—	100.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1150%)	N/M	100.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1150%)	N/M	N/M	-99.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1345%)	N/M	24.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+201%)	395.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4844%)	29666.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+370726%)	—	—	—	21.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+163%)	—	—	—	—	—	—	—
EPS Growth YoY (%)	11.9% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	48.1% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	65.4% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	57.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	76.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	N/M	N/M	N/M	N/M	N/M	—	85.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	73.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	72.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	-15.0% Weak ↓ Weak Declining Year-over-year change in net income	12.1% Fair ↓ Fair Declining Year-over-year change in net income	69.8% Excellent → Excellent Stable Year-over-year change in net income	69.8% Excellent Excellent Year-over-year change in net income	69.8% Excellent Excellent Year-over-year change in net income	N/M	N/M	N/M	N/M	N/M	N/M	N/M	N/M	-50.7% Weak ↑ Weak Improving Year-over-year change in net income	-229.5% Weak → Weak Stable Year-over-year change in net income	-229.5% Weak Weak Year-over-year change in net income	-229.5% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	28.2% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	—	46.7% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	71.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-5572.9% Weak Weak Year-over-year change in free cash flow	—	-645.1% Weak Weak Year-over-year change in free cash flow	—	89.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	13.4% Good Good Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	-137.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1019%)	1.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-88%)	18.2% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+22%)	20.6% Good ↑ Good Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+37%)	-2.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-119%)	-203.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1458%)	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	-0.1% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	26.9% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	8.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-12.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	-134.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1217%)	4.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-64%)	1.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-87%)	1.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-87%)	2.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-82%)	-195.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1726%)	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	-0.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	12.2% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	-5.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-7.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-229.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.70x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.57x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.00x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	2.79x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-3.51x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	-3.38x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.18x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.86x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.45x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	-12.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-25.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-38.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-37.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	0.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.2% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	4.8% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	-0.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-37.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	14.8% Good → Good Stable Return earned on debt + equity capital invested Optimal: > 10%	14.6% Good → Good Stable Return earned on debt + equity capital invested Optimal: > 10%	14.4% Good Good Return earned on debt + equity capital invested Optimal: > 10%	15.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-14.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-11.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-21.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-29.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	0.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	4.5% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-0.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-30.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-17.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-15.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-201%)	-10.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-172%)	-10.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-172%)	-21.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-243%)	-17.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-219%)	-22.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-252%)	-60.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-504%)	-45.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-403%)	-36.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-344%)	1.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-93%)	0.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-97%)	0.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-97%)	0.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-97%)	-12.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-184%)	-33.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-321%)	-24.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-265%)	-19.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-232%)	18.8% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+25%)	11.7% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-22%)	14.3% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	21.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+45%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Net Debt (USD)	$-229.14M	$-226.65M	$-225.18M	$-58.09M	$-59.76M	$-77.39M	$-71.84M	$-75.00M	$-170.55M	$-170.20M	$-135.26M	$-247.76M	$-114.56M	$-62.53M	$-107.73M	$-67.44M	$-110.40M	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	—	—	$0.00	$0.00	$0.00	—	$0.01	$-0.02	$1.31	—	$1.52	$1.46	$1.07	—	$0.01	—	—	—	$0.04	—	—	—
Basic EPS, GAAP (USD)	$-0.37	$-0.28	$-0.37	$-0.46	$-0.42	$-0.54	$-1.07	$-1.07	$-1.75	$0.07	$0.31	$0.33	$0.02	$-0.62	$-0.92	$-0.93	—	$-4.15	$-3.42	$-3.41	—	—
Free Cash Flow per Share (USD)	$-0.33	—	$-0.33	$-0.28	$-0.46	—	$-0.61	$-0.98	$-0.01	—	$-0.08	—	$-0.08	—	—	—	—	—	$-3.11	$-2.03	—	—
Book Value per Share (USD)	$2.46	$2.78	$3.02	$1.88	$2.26	$2.40	$2.88	$3.84	$4.77	$6.40	$6.21	$5.74	$5.26	$5.12	$2.46	$3.29	$4.16	—	$-18.36	$-15.84	—	—
Tangible Book Value per Share (USD)	$2.46	$2.78	$3.02	$1.88	$2.26	$2.40	$2.88	$3.84	$4.77	$6.40	$6.21	$5.74	$5.26	$5.12	$2.46	$3.29	$4.16	—	$-18.36	$-15.84	—	—
Basic Weighted Avg Shares (shares)	110.56M	—	93.33M	89.14M	85.70M	—	68.09M	68.02M	67.85M	—	67.41M	67.23M	66.72M	—	58.53M	58.28M	—	—	6.76M	6.43M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$269.06M	$300.98M	$327.59M	$165.47M	$198.21M	$161.03M	—	—	$318.89M	$382.62M	—	$363.31M	$337.44M	$335.52M	$139.55M	$188.97M	$237.78M	—	—	—	—	—
Total Equity (USD)	$273.16M	$305.26M	$332.00M	$167.88M	$201.42M	$164.76M	$196.20M	$261.31M	$324.44M	$433.43M	$418.40M	$386.37M	$352.65M	$340.61M	$144.03M	$192.79M	$240.95M	$-151.17M	$-124.07M	$-101.89M	$-66.72M	$-66.72M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	—	$0.00	$0.00	$0.00	$0.00	$-665.00K	$416.00K	$-1.02M	$88.64M	$108.45M	$102.69M	$98.22M	$71.43M	$21.89M	$345.00K	—	—	$0.00	$285.00K	—	—	—
Depreciation Expense (USD)	$98.00K	$108.00K	$120.00K	$141.00K	$156.00K	$160.00K	$221.00K	$208.00K	$315.00K	$301.00K	$302.00K	—	$204.00K	$182.00K	—	—	$35.00K	$22.00K	$10.00K	$10.00K	$10.00K	—
Net Income, GAAP (USD)	$-41.28M	$-33.00M	$-35.91M	$-35.91M	$-35.91M	$-37.55M	$-118.79M	$-118.79M	$-118.79M	$4.73M	$1.57M	$1.57M	$1.57M	$-42.70M	$-47.85M	$-47.85M	$-47.85M	$-28.34M	$-14.52M	$-14.52M	$-14.52M	—
Operating Cash Flow (USD)	$-36.88M	$-27.90M	$-30.37M	$-25.25M	$-39.82M	$-59.01M	$-41.57M	$-66.58M	$-489.00K	$13.55M	$-5.17M	—	$-5.07M	$-49.70M	—	—	$-40.63M	$-28.24M	$-20.86M	$-13.05M	$-12.64M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 22 quarters

Amylyx Pharmaceuticals, Inc.

Analytical Summary

22-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AMLX with peers